05 Dec 2018
Mereo Biopharma and Oncomed Pharmaceuticals Joint Conference Call
08 Aug 2018
Unaudited interim results for the six month period ended June 30, 2018
03 Apr 2018
Annual Report 2017
23 Mar 2018
Preliminary Results for the Year Ended December 31 2017
08 Aug 2017
Interim results for the period ended 30 June 2017

Corporate Presentation

View our latest Corporate Presentation


NASDAQ Share Price Chart

Mereo is a specialty biopharma company developing innovative medicines for patients. Find out about our share price and latest trades.

View share price chart